Results 131 to 140 of about 236,205 (303)
Reciprocal co-expression of Fas and Fas ligand in human cholangiocarcinoma.
, 2007 We have previously characterized the role of Fas in tumorigenesis using two cholangiocarcinoma cell lines expressing high (Fas(H)) and low (Fas(L)) levels of Fas.Jhala, Nirag C, Ahn, Eun-Young, Pan, George, McDonald, Jay M, Chen, Yabing, Feng, Gong, MD, PhD, Reddy, Vishnu +6 morecore +1 more sourceT cells, the Next Big Target in Axial Spondyloarthritis?
Arthritis &Rheumatology, EarlyView.Axial spondyloarthritis (axSpA) is a chronic inflammatory disease characterized by complex immune dysregulation, with T cells playing a central role in its pathogenesis. In this review, we synthesize current knowledge on diverse T cell subsets in axSpA, their pathogenic mechanisms, and emerging therapeutic strategies targeting these cells. We highlight Mansi K. Aparnathi, Nigil Haroonwiley +1 more sourcePharmacokinetics, Effectiveness and Safety of Certolizumab Pegol in Children and Adolescents With Active Juvenile Idiopathic Arthritis: 9+‐Year Results From a Multicenter, Open‐Label Study
Arthritis &Rheumatology, EarlyView.Objective
The purpose of this study was to assess the pharmacokinetics, effectiveness, safety, and immunogenicity of certolizumab pegol (CZP) in polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods
Pediatric Arthritis Study of Certolizumab Pegol (NCT01550003), a multicenter, open‐label study, enrolled patients aged 2 to 17 years with ...Hermine I. Brunner, Lyudmila Grebenkina, Irina Nikishina, Ekaterina Alexeeva, Vyacheslav Chasnyk, Carlos Abud‐Mendoza, Nadina Rubio‐Pérez, Heinrike Schmeling, María del Rocio Maldonado‐Velázquez, Diane Brown, Andrew Zeft, Esi Morgan, C. Egla Rabinovich, Daniel Kingsbury, Hulya Bukulmez, Beth Gottlieb, Thomas Griffin, Lisa Imundo, Stacey Tarvin, Earl Silverman, Laura Shaughnessy, Saori Shimizu, Paulette Williams, Rocío Lledó‐García, Gauri Utturkar, Baran Ufuktepe, Alberto Martini, Daniel J. Lovell, Nicolino Ruperto, the Paediatric Rheumatology International Trials Organisation (PRINTO); the Pediatric Rheumatology Collaborative Study Group (PRCSG), Hermine I. Brunner, Lyudmila Grebenkina, Irina Nikishina, Ekaterina Alexeeva, Vyacheslav Chasnyk, Carlos Abud‐Mendoza, Nadina Rubio‐Pérez, Heinrike Schmeling, María del Rocio Maldonado‐Velázquez, Diane Brown, Andrew Zeft, Esi Morgan, C. Egla Rabinovich, Daniel Kingsbury, Hulya Bukulmez, Beth Gottlieb, Thomas Griffin, Lisa Imundo, Stacey Tarvin, Earl Silverman, Alberto Martini, Daniel L. Lovell, Nicolino Ruperto +52 morewiley +1 more sourcePlasma Proteome Reflects Tissue Damage and Clinical Manifestations in Patients With Inflammatory Myopathies
Arthritis &Rheumatology, EarlyView.Objective
Tissue‐specific biomarkers that are reliable and associated with clinical manifestations of idiopathic inflammatory myopathy (IIM) are lacking. The blood circulation in individuals serves as a central conduit, allowing communication between tissues and facilitating clearance and recycling of tissue‐derived proteins.Yue‐Bei Luo, Josefin Kenrick, Angeles S. Galindo‐Feria, Antonella Notarnicola, Ana Daniela Ulloa Navas, Irene Peralta‐Garcia, Orane Demuynck, Andrea Kemp, Valérie Leclair, Karin Lodin, Eveline Van Gompel, Lara Dani, Fabricio Espinosa‐Ortega, Maryam Dastmalchi, Leonid Padyukov, Charlotta Preger, María Bueno Álvez, Mathias Uhlén, Peter Nilsson, Fredrik Edfors, Lina‐Marcela Diaz‐Gallo, Elisa Pin, Ingrid E. Lundberg, Begum Horuluoglu +23 morewiley +1 more sourcePersistent Interleukin‐18 Fuels Expansion of CD38+HLA‐DR+CD8+ T Cells in Still Disease and Macrophage Activation Syndrome
Arthritis &Rheumatology, EarlyView.Objective
Still disease (SD) is an autoinflammatory disorder characterized by remarkably high interleukin‐18 (IL‐18) levels. Increasing evidence suggests that adaptive immunity also contributes to its pathogenesis, particularly in refractory courses. Macrophage activation syndrome (MAS), one of SD's most severe complications, is associated with further Greta Rogani, Remco G. A. Erkens, Alejandra Bodelón, Tim R. Mocking, Marein T. M. Putmans, Freya M. C. H. Huijsmans, Lyanne J. P. M. Sijbers, Aafke M. De Ligt, Maurice J. H. Van Haaren, Rianne C. Scholman, Noël M. M. Dautzenberg, Joyce I. Meesters‐Ensing, Martina Rossano, Laura Porretti, Stefan Nierkens, Francesca S. Minoia, Sebastiaan J. Vastert, Jorg van Loosdregt +17 morewiley +1 more sourceNon-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells [PDF]
Defective FAS (CD95/Apo-1/TNFRSF6) signaling causes autoimmune lymphoproliferative syndrome (ALPS). Hypergammaglobulinemia is a common feature in ALPS with FAS mutations (ALPS-FAS), but paradoxically, fewer conventional memory cells differentiate from ...Olbrich, P., Voll, Reinhard E., Catala, A., Voll, R.E., Andrieux, G., Fuentes, Manuel, Stuchly, J., de la Calle, O., Staniek, Julian, Smulski, Cristian Roberto, Díez García, Paula, Neumann, J., Arpesella, L., Benes, Vladimir, Böhler, Chiara, Neth, O., Rieux-Laucat, F., Alsina, L., Olbrich, Peter, Boerries, M., Gonzalez-Granado, Luis I., Raabe, J., Smulski, C.R., Rensing-Ehl, Anne, Bakardjieva, M., García-Valiente, Rodrigo, Schwenk, Sabine, Fernández-García, Jonatan, Bakardjieva, Marina, Carsetti, Rita, Carsetti, R., Neumann, Julika, Fernández García, J., Alsina, Laia, Andrieux, Geoffroy, Magerus, A., Schneider, P., Mielenz, Dirk, García Valiente, R., Stuchly, Jan, Rieux-Laucat, Frédéric, Rensing-Ehl, A., Mielenz, D., Ehl, S., Stancikova, Jitka, Warnatz, K., Schwenk, S., Rizzi, Marta, Kalina, Tomas, Warnatz, Klaus, Neven, B., Boerries, Melanie, Ehl, Stephan, Allende, Luis M., de la Calle, Oscar, Kalina, T., Venhoff, Nils, Benes, V., Neth, Olaf, Fuentes, M., Raabe, Jan, Seidl, M., Piano Mortari, Eva, Janowska, I., Unger, Susanne, Venhoff, N., Janowska, Iga, Fernández García, Jonatan, Catalá, Albert, García Valiente, Rodrigo, Allende, L.M., González-Granado, Luis, Neven, Bénédicte, Calle, Oscar de la, Staniek, J., Böhler, C., Allende, Luis, Thiel, J., Díez, Paula, Díez, P., Lorenzetti, Raquel, Rizzi, M., Sogkas, G., Thiel, Jens, Stancikova, J., Lorenzetti, R., Piano Mortari, E., Schneider, Pascal, Magerus, Aude, Unger, S., Arpesella, Leonardo, Sogkas, Georgios, Gonzalez-Granado, L.I., Seidl, Maximilian, Rieux Laucat, Frédéric, Seidl, Theodor Maximilian, Rensing Ehl, Anne, Allende Martínez, Luis Miguel, Voll, Reinhard, González Granado, Luis Ignacio +99 morecore +1 more sourceAMETHYST: A Retrospective Cohort Study of Treatment Patterns and Outcomes in Patients With Glucocorticoid‐Refractory Macrophage Activation Syndrome Complicating Still's Disease
Arthritis &Rheumatology, EarlyView.Objective
Information is limited on the natural history and current treatment patterns in macrophage activation syndrome (MAS), a life‐threatening hyperinflammatory syndrome complicating Still's disease (systemic juvenile idiopathic arthritis [sJIA] and adult‐onset Still's disease [AOSD]).Alexei Grom, Jordi Antón, Edward M. Behrens, Corey Best, Norbert Blank, Josefin Blomkvist, Scott W. Canna, Sonia Carriquí, Shanmuganathan Chandrakasan, Andrew Danquah, Ngoc‐Bao Duong, Brian D. Jamieson, Paivi Miettunen, Abiola Oladapo, Sampath Prahalad, Pierre Quartier, Grant Schulert, Anna Stoltenberg, Uwe Ullmann, Erika Van Nieuwenhove, Sebastiaan J. Vastert, Fabrizio De Benedetti +21 morewiley +1 more sourceOutcomes of Tapering Biologic and Targeted Synthetic Disease‐Modifying Antirheumatic Drugs in Rheumatoid Arthritis: A Multicenter Randomized Noninferiority Trial
Arthritis &Rheumatology, EarlyView.Objective
Evidence supporting tapering of biologic or targeted synthetic disease‐modifying antirheumatic drugs (b/tsDMARDs) in patients with rheumatoid arthritis (RA) with sustained low disease activity (LDA) remains limited. We evaluated the efficacy and safety of a structured b/tsDMARD‐tapering strategy in patients with RA who had achieved sustained ...Dong‐Jin Park, Sung‐Eun Choi, Ji‐Hyoun Kang, Jung‐Yoon Choe, Hye‐Soon Lee, So‐Young Bang, Yun‐Hong Cheon, Sang‐Il Lee, Mingyo Kim, Yoon‐Kyoung Sung, Soo‐Kyung Cho, Jae Hyun Jung, Sung Hae Chang, Sung Won Lee, Yeon‐Ah Lee, Seung‐Geun Lee, Hyun‐Sook Kim, Seung‐Ki Kwok, Seung‐Cheol Shim, Shin‐Seok Lee +19 morewiley +1 more sourceAlterations of Fas and Fas-Related Molecules in Patients with Silicosis
, 2006 Persons with silicosis have not only respiratory disorders but also autoimmune diseases. To clarify the mechanisms involved in the dysregulation of autoimmunity found in patients with silicosis, we have been focusing on Fas and Fas-related molecules in ...Masayasu Kusaka, Yasumitsu Nishimura, Masafumi Tomita, Akiko Takata, Takemi Otsuki, Fuminori Hyodoh, Hironobu Katsuyama, Takumi Kishimoto, Yoshie Miura, Ayako Ueki +9 morecore +1 more sourceEfficacy, safety and cost‐effectiveness of CAR‐T therapy
British Journal of Clinical Pharmacology, EarlyView.CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL.
Innovations target solid tumours despite challenges such as antigen escape.
Combination therapies enhance the delivery and infiltration of CAR T cells.
Toxicity, cost and resistance remain major barriers to clinical use.Emina Karahmet Sher, Amina Džidić‐Krivić, Emma Pinjic, Nejra Selak, Kanita Omerbasic, Alexandar Chupin, Andrej Belancic, Almir Fajkic +7 morewiley +1 more source